Search Results - "Tanghetti, E A"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    The noncompliant patient with acne by Tanghetti, E A

    Published in Skin therapy letter (01-11-2011)
    “…Clinical studies with topical and systemic agents for acne show remarkable improvement over a 3 month period of time, with continued progress in long-term use…”
    Get more information
    Journal Article
  2. 2

    Long Pulse 532‐nm Laser Treatment of Facial Telangiectasia by ADRIAN, ROBERT M., TANGHETTI, EMIL A.

    Published in Dermatologic surgery (01-01-1998)
    “…background. Facial telangiectasias are a frequently observed cosmetic concern. Current therapeutic modalities have certain side effects and limitations. We…”
    Get full text
    Journal Article
  3. 3

    An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid by Tanghetti, E A

    Published in Cutis (New York, N.Y.) (01-12-2000)
    “…A large-scale observation study has been performed to evaluate how tazarotene is used to treat plaque psoriasis in everyday clinical practice and to elucidate…”
    Get full text
    Journal Article
  4. 4

    Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial by Webster, G F, Berson, D, Stein, L F, Fivenson, D P, Tanghetti, E A, Ling, M

    Published in Cutis (New York, N.Y.) (01-06-2001)
    “…Tazarotene 0.1% gel and tretinoin 0.025% gel are both effective in the treatment of acne vulgaris. Results of a multicenter, double-blind, randomized,…”
    Get full text
    Journal Article
  5. 5

    An observation study evaluating the efficacy of tazarotene plus corticosteroid in treating plaque psoriasis in patients switched from treatment with calcipotriene +/- corticosteroid by Tanghetti, E A

    Published in Cutis (New York, N.Y.) (01-12-2000)
    “…The results of a multicenter, open-label observation study evaluating the use of tazarotene in 1393 patients being treated for plaque psoriasis have been…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Complications of laser dermatologic surgery by Willey, Andrea, Anderson, R. Rox, Azpiazu, Jose L., Bakus, Abnoeal D., Barlow, Richard J., Dover, Jeffrey S., Garden, Jerome M., Kilmer, Suzanne L., Landa, Nerea, Manstein, Dieter, Ross Jr, E. Victor, Sadick, Neil, Tanghetti, Emil A., Yaghmai, Dina, Zelickson, Brian D.

    Published in Lasers in surgery and medicine (01-01-2006)
    “…Background and Objective Innovations in lasers, light and radiofrequency devices have allowed for improved therapeutic efficacy and safety and the ability to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Multipass Treatment of Photodamage Using the Pulse Dye Laser by Tanghetti, Emil A., Sherr, Evan A., Alvarado, Shea L.

    Published in Dermatologic surgery (01-07-2003)
    “…Background. Pulse dye lasers (PDLs) alter structural proteins in scars and photodamaged skin, in addition to their effects on dermal vasculature. The PDL has…”
    Get full text
    Journal Article
  10. 10

    A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage by Kang, Sewon, Krueger, Gerald G., Tanghetti, Emil A., Lew-Kaya, Deborah, Sefton, John, Walker, Patricia S., Gibson, John R., Tazarotene Cream in Photodamage Study Group

    “…Previous studies indicate that tazarotene is efficacious in reducing signs of photodamage. We sought to confirm the efficacy and tolerability of tazarotene…”
    Get full text
    Journal Article
  11. 11

    Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial by Leyden, James J, Tanghetti, Emil A, Miller, Bruce, Ung, Mark, Berson, Diane, Lee, Jeff

    Published in Cutis (New York, N.Y.) (01-02-2002)
    “…The efficacy and tolerability of tazarotene 0.1% gel and tretinoin 0.1% microsponge gel were evaluated in a multicenter, double-blind, randomized,…”
    Get full text
    Journal Article
  12. 12

    Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: Results of a prospective patient series by TANGHETTI, Emil A

    Published in Cutis (New York, N.Y.) (01-02-2003)
    “…The cause of the selective melanocyte destruction in vitiligo may be due to an autoimmune disorder. A series of 15 patients with vitiligo were treated with a…”
    Get full text
    Journal Article
  13. 13

    Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy by Draelos, Zoe Diana, Tanghetti, Emil A

    Published in Cutis (New York, N.Y.) (01-02-2002)
    “…A multicenter, investigator-masked, randomized, parallel-group study was performed in 440 patients with mild-to-moderate facial acne vulgaris to compare the…”
    Get full text
    Journal Article
  14. 14

    Combination therapy is the standard of care by Tanghetti, Emil A

    Published in Cutis (New York, N.Y.) (01-08-2005)
    “…Acne is a multifactorial disease characterized by abnormalities in sebum production, follicular epithelial desquamation, bacterial proliferation, and…”
    Get full text
    Journal Article
  15. 15

    Topical tazarotene in acne vulgaris: treatment approaches by Anderson, Dina N, Callender, Valerie D, Del Rosso, James Q, Tanghetti, Emil A, Zane, Lee T

    Published in Cutis (New York, N.Y.) (01-10-2004)
    “…Topical tazarotene is effective and well tolerated in the treatment of acne vulgaris and has been used successfully in diverse patient populations. However,…”
    Get full text
    Journal Article
  16. 16

    专家组为医生提供治疗酒渣鼻的新建议 by Schaller, M., Almeida, L.M.C., Bewley, A., Cribier, B., Del Rosso, J., Dlova, N.C., Gallo, R.L., Granstein, R.D., Kautz, G., Mannis, M.J., Micali, G., Oon, H.H., Rajagopalan, M., Steinhoff, M., Tanghetti, E., Thiboutot, D., Troielli, P., Webster, G., Zierhut, M., Zuuren, E.J., Tan, J.

    Published in British journal of dermatology (1951) (01-05-2020)
    “…Summary 酒渣鼻是一种主要影响面部皮肤和眼睛的皮肤病。它有许多不同的可见体征和症状,或“特征”。 医生目前正在从一种亚型方法(指定疾病特征分组)转换为一种表型方法,该方法将每个患者看为一个具有其自身特定特征的个体。 2019 ROSCO 小组(专家组)旨在提出建议和制定方法来帮助医生使用表型方法治疗酒渣鼻患者。…”
    Get full text
    Journal Article